Bausch & Lomb Incorporated

This study was designed to check the long-term safety of a new eye drop combination for people with dry eye disease. It planned to follow participants for 12 months to see if any side effects occurred. However, the trial was withdrawn before any volunteers were enrolled.

This early-stage study tests a new eye drop called BL1332 in 24 healthy adults aged 18 to 50. The goal is to see if the drops are safe and tolerable, and to find the highest dose that can be given without causing serious side effects. This research is a first step toward possibly…